Novartis Oncology VP of Sales Salary | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology VP of Sales Salary

The average Novartis Oncology VP of Sales earns an estimated $271,872 annually, which includes an estimated base salary of $185,203 with a $86,669 bonus. Novartis Oncology's VP of Sales compensation is $2,364,325 less than the US average for a VP of Sales. VP of Sales salaries at Novartis Oncology can range from $235,006 - $325,000.

The Sales Department at Novartis Oncology earns $178 more on average than the IT Department.

Last updated 3 years ago.

$60k
$122k
$212k
$300k
$3.56B
$271,872
Average Compensation
$185,203
avg. base
$86,669
avg. bonus

VP of Sales Salaries at Novartis Oncology

VPs of Sales earn $38,312 more than Directors of Sales.

Director of Sales
$234k*
Sales Manager
$183k*
Sales Engineer
$159k*
Sales Rep
$149k*
Sales Associate
$94k*
* estimated salary

Compensation at Novartis Oncology by Department

The Sales Department averages $178 more than the IT Department, and $8,635 less than the Customer Support Department

Customer Support
$123,374 Avg. total comp.
+$9k
Sales
$114,739 Avg. total comp.
IT
$114,561 Avg. total comp.
-$178

VP of Sales Compensation by Gender (All Companies)

The average female VP of Sales at companies similar size to Novartis Oncology reported making $326,625, while the average male VP of Sales at similar sized companies reported making $314,005.

VP of Sales Compensation by Ethnicity (All Companies)

The average Hispanic or Latino VP of Sales at companies similar size to Novartis Oncology reported making $371,333, while the average Asian or Pacific Islander VP of Sales at similar sized companies reported making $260,050.

How VPs of Sales at Novartis Oncology Rate Their Compensation

The majority of VPs of Sales at Novartis Oncology believe they're not compensated fairly. 100% of VPs of Sales at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company